DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Olsson SB. Executive Steering Committee of the SPORTIF III Investigators.
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
Lancet 2003;
362 (9397) 1691-1698
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.